Global Clinical and Translational Research > 2022; Volume 4

2022; Volume 4

Glob Clin Transl Res. 2022; Vol 4, No 4

Pharmacovigilance Principles: The Building Blocks of Benefit-Risk Assessments. R. Piccirillo and J Parish Glob Clin Transl Res. 2022; 4(4): 1-7. HTML PDF. DOI:10.36316/gcatr.04.0045. Advanced online October 17, 2022. Google Scholar.

Figure 2. Overview of the drug approval process

Structured Benefit-Risk Assessments: An Illustrative Case Study of Paracetamol. R Piccirillo and J Parish Glob Clin Transl Res. 2022; 4(4): 8-15. HTML, PDF. Advanced online October 17, 2022. DOI:10.36316/gcatr.04.0046. Google Scholar.

Figure 1. Factors contributing to the sBRA for paracetamol
Figure 2. Example value tree presentation of the benefits and risks of paracetamol